World's Best Scientists 2026 revealed!
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
146
Citations
115706
World Ranking
1314
National Ranking
17

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Ludwig Kappos is affiliated with the University Hospital of Basel in Switzerland and contributes extensively to medical research, with a particular focus on multiple sclerosis and related neurological disorders.

The scientist's work spans the broader field of medicine, notably within subfields such as pathology and forensic medicine, neurology, radiology, nuclear medicine and imaging, oncology, and molecular biology.

Kappos has authored numerous papers, including recent publications such as:

  • Ofatumumab versus Teriflunomide in Multiple Sclerosis, 2020, New England Journal of Medicine
  • 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis, 2021, The Lancet Neurology
  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials, 2020, JAMA Neurology
  • Neurofilaments as biomarkers in neurological disorders - towards clinical application, 2024, Nature Reviews Neurology
  • MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice, 2020, Nature Reviews Neurology

The primary topics of Kappos's research include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Polyomavirus and related diseases
  • Advanced Neuroimaging Techniques and Applications
  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies
  • Advanced MRI Techniques and Applications

Frequent coauthors who have collaborated with Kappos include:

  • Jens Kühle
  • Cristina Granziera
  • Xavier Montalbán
  • Matthias Weigel
  • David Leppert

Most of the scientist's work appears in specific publication venues, reflecting a consistent contribution to the field. These venues include:

  • Neurology
  • Multiple Sclerosis Journal
  • Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
  • Journal of Neurology
  • Neurology Neuroimmunology & Neuroinflammation

Best Publications

  • Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

    Chris H Polman;Stephen C Reingold;Brenda Banwell;Michel Clanet

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

    Chris H. Polman;Stephen C. Reingold;Gilles Edan;Massimo Filippi

  • A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

    Chris H. Polman;Eva Havrdova;Michael Hutchinson;Ludwig Kappos

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

    Ludwig Kappos;Ernst Wilhelm Radue;Paul O'Connor;Chris Polman

  • Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

    Jeffrey A. Cohen;Frederik Barkhof;Giancarlo Comi;Hans Peter Hartung

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Ralf Gold;Ludwig Kappos;Douglas L Arnold;Amit Bar-Or

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Neurofilaments as biomarkers in neurological disorders

    Michael Khalil;Charlotte E. Teunissen;Markus Otto;Fredrik Piehl

  • Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

    Ludwig Kappos;Jack Antel;Giancarlo Comi;Xavier Montalban

  • Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

    Paul O'Connor;Jerry S Wolinsky;Christian Confavreux;Giancarlo Comi

  • Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

    Giulio Disanto;Christian Barro;Pascal Benkert;Yvonne Naegelin

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

    Massimo Filippi;Maria Assunta Rocca;Olga Ciccarelli;Olga Ciccarelli;Nicola De Stefano

  • Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

    Philip L De Jager;Philip L De Jager;Xiaoming Jia;Joanne Wang;Paul I W de Bakker

  • Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

    Ludwig Kappos;David Li;Peter A Calabresi;Paul O'Connor

  • Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

    Peter A. Calabresi;Ernst Wilhelm Radue;Douglas Goodin;Douglas Jeffery

  • Differential diagnosis of suspected multiple sclerosis: a consensus approach

    D. H. Miller;B. G. Weinshenker;M. Filippi;B. L. Banwell

Frequent Co-Authors

Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Frederik Barkhof
Frederik Barkhof University College London
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Jerry S. Wolinsky
Jerry S. Wolinsky The University of Texas Health Science Center at Houston
Stephen L. Hauser
Stephen L. Hauser University of California, San Francisco
Eva Havrdova
Eva Havrdova Charles University
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Amit Bar-Or
Amit Bar-Or University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative health and nursing pathways in the U.S. can open new doors for medical careers. For those interested in advanced roles, online phd programs nursing offer flexibility and the opportunity to specialize, often at reduced tuition compared to on-campus options.

For registered nurses seeking career advancement, an online Bachelor of Science in Nursing is a practical next step. Understanding rn to bsn online cost can help prospective students compare programs and make informed financial decisions.

Non-nurses who wish to fast-track their entry into the field can consider direct entry msn programs. These accelerated programs allow individuals with non-nursing degrees to earn a master’s and quickly begin a new healthcare career.

For those seeking an accessible start, researching the adn programs can be a great option. These programs often offer flexible admissions and serve as a pathway to becoming a registered nurse.

Best Scientists Citing Ludwig Kappos

Trending Scientists

Recently Published Articles